Different approaches have been used to delineate the pathway of B lymphocyte differentiation and to define functional B cell subsets. The heterogeneity of B cells is reflected in their physical properties-e.g., size distribution (1) and charge (2)-as well as in their expression of surface markers, such as immunoglobulin isotypes (3) , I region associated antigens (4), complement receptor (5) , and Pc-i, a plasma cell antigen (6) . The appearance of the various Ig isotypes during ontogeny (7) and the differential expression of IgD during the development of a memory response (8, 9) have been analyzed in detail. Since the discovery of Ia antigens there have been numerous reports on their presence on lymphocyte subpopulations: thus, Ia antigens are expressed on functional subsets of T cells (10, 11) and macrophages (12) . However, Ta antigens are expressed on virtually all B cells, appearing very early in ontogeny (13) .
A different approach to define B cell subsets has been reported in which an antiserum was raised against a differentiation marker using the CBA/N (N) mutant strain (14) . The functional defects of these mice have been well characterized by many investigators (15) (16) (17) ; the mice lack a subpopulation of B cells that appears late in ontogeny and responds to thymus-independent type 2 antigens (18) . Because the defect is X-linked and recessive, the results of an N Y by BALB/c 6 cross will yield defective F1 6 and normal F1 Y offspring. By immunizing defective F1 6 with BALB/c spleen cells it was possible to raise an antiserum, anti-Lyb3, that reacted exclusively with a subset of B cells in all mouse strains except N. It was also shown that Lyb3 is a receptor for triggering signal(s) (14, 19 reaction was stopped by addition of 80,l of cold medium and the viable cells were counted with phase contrast microscopy. The percent specific killing was calculated as:
(% dead cells with antiserum -% dead cells with NMS) X 100 100% -% dead cells with NMS Background killing in the NMS control was between 5% and 15%; killing with antilymphocyte serum (1:5) was 100%.
RESULTS
Characterization of Antiserum. The (N X B6)F1 6 anti-B6 serum (NaB6) was first screened for noncytotoxic, nonstrain-restricted anti-LybS activity in a functional enhancement assay, as described (14) . Most batches of antisera contained anti-Lyb3 antibodies. In, addition, some batches contained cytotoxic antibodies which lysed 25-30% of B6 spleen cells in dilutions up to 1:80 (Fig. 1) . The specificity of this cytotoxic reaction was determined in absorption experiments (Fig. 2) . Aliquots of antisera (10 ,ul) were absorbed with increasing numbers of spleen cells and then tested for lysis of B6 spleen cells in a microcytotoxicity assay. B6(5 X 106) and, to a lesser but significant degree, (N X B6)F1 Q (107) spleen cells removed the cytotoxic activity completely, whereas (N X B6)F1 6 spleen cells were unreactive, even at the highest concentration (107).
Strain Distribution. (See Table 1 .) The NaB6 serum killed B6 but not BALB/c or CBAH/T6 spleen cells. To examine this in more detail, mice with the various H-2 haplotypes and their congenic partners on the B10 and C3H background were tested.
Spleen cells from all mice with the H-2b haplotype and Fis thereof were positive (25-35% specific killing), regardless of the background, whereas all mice expressing different H-2 haplotypes were negative. As a positive control the various strains were tested with the relevant anti-Ia sera, which lysed 90-95% of all B cells (45-67% of whole spleen cells). Antilymphocyte serum plus C killed 100% of the spleen cells. Confirming the absorption experiments (Fig. 2) , (N x B6)F1 9 spleen cells were positive and (N X B6)F1 6 spleen cells were negativee.
Mapping of the Gene(s) Coding for H-2b Specific Marker.
(See Table 2 .) H-2b recombinant mice were used to define the region within the major histocompatibility complex (MHC) that codes for the marker recognized by the NaB6 serum. [BlO.A(5R)], whereas strains expressing b alleles to the right only of I-A were negative [B1O.A(4R)]. Because B10.MBR (Kb, I-Ak) was negative, it can be concluded that at least one gene coding for the marker maps within the I-A region of the MHC, but we cannot exclude the possibility that a second gene in the I-B region is necessary for expression of the marker. Lack of the relevant recombinant mice does not allow a precise definition of the genes involved. GLO genes a and ,3, which map in the I-C and I-A subregions, respectively, and are both necessary for an immune response to GL4O (26) .
Analysis of lymphocyte subpopulations showed that the marker defined here has the same tissue distribution as Lyb3. (Table 1) . These results strongly indicate that the marker recognized by the NaB6 serum is a specificity different from previously described Ta antigens. It will be of interest to absorb conventional a-Ia sera with spleen cells from defective F1 6 mice to test for remaining antibodies with specificity for a B cell subset. It may be that conventional alloimmunizations evoke little or no antibody to this B cell marker. Immunoprecipitations from radioiodinated spleen cells should be useful in studying the molecular nature of the new antigen and its relationship to the defined Ia specificities coded for by the I-A region of the MHC. The fact that this new surface marker is encoded by a gene within the I-A region of the H-2 complex and is selectively expressed on a functional subpopulation of B cells leads to speculation as to its direct functional relevance. Cell interaction genes controlling optimal T-B cell cooperation have been mapped to the I-A, I-B, or both subregions of the MHC (27) (28) (29) . Accessory cells (macrophages ?) are the antigen-presenting cells in the T-B cell interaction, and it has been shown that they, too, require identity of the I-A region with T and B cells for effective interaction to take place (28, 29) . In addition, both macrophages and B cells express the immune response genes, mapped in the I-A region, which determine high or low responsiveness to poly(L-Tyr,L-Gln)-poly(DL-Ala)--poly(L-Lys) (29) . Because it is known that a subset of macrophages (12) and dendritic cells (30) express Ia antigens, it will be interesting to examine if they also express the surface marker recognized by the NaB6 serum. It should be informative to test the ability of the specific antiserum to deplete relevant subsets of B cells and accessory cells or to block these various cell interactions.
The expression of both Lyb3 and the surface marker defined here is controlled by a gene on the X chromosome (xid) (31), because they both fail to develop in the defective F1 6 mice. xid inhibits either the total development of a whole subset of B cells or only the specific appearance of these B cell differentiation markers. If the latter case is true, one might expect a structural or organizational relationship between the genes coding for these markers. I 
